RETN and breast carcinoma: This indirect mechanism is noticeably distinct from the direct effect of resistin on breast cancer cells, such as the enhanced tumor growth and metastatic ability of breast cancer cells via toll-like receptor 4 (TLR4) or adenylyl cyclase-associated protein 1 (CAP1)-mediated pathways15,39.